Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lotemax vs Zylet in MGD and Posterior Blepharitis
NCT01456780Phase 4Completed
- Sponsor
- Massachusetts Eye and Ear
- Start
- Aug 2011
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tobramycin + dexamethasone in meibomian gland dysfunction (MGD), posterior blepharitis, sponsored by Massachusetts Eye and Ear. Started Aug 2011; status: completed.
02
Drugs
tobramycin + dexamethasone
03
Conditions
meibomian gland dysfunction (MGD)posterior blepharitis
Beyond the preview
Go deeper on NCT01456780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456780.